Catalyst Biosciences, Inc.
(NASDAQ:CBIO)
$0.51
-0.01 (-2.67%)
Open: 1:36 PM
CBIO Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
CBIO Stock Price Today
Catalyst Biosciences, Inc. (CBIO) stock declined over -96.66% intraday to trade at $0.5113 a share on NASDAQ. The stock opened with a loss of -96.29% at $0.57 and touched an intraday high of $0.58, falling -96.66% against the last close of $15.29. The Catalyst Biosciences, Inc. in stock market went to a low of $0.48 during the session.
CBIO Stock Snapshot
$15.29
Prev. Close
1.22 Billion
Market Cap
$0.48
Day Low
$0.57
Open
N/A
Number of Shares
$0.58
Day High
N/A
P/E ratio
-17.57
EPS (TTM)
N/A
Cash Flow per Share
N/A
Free Float in %
N/A
Book Value
Volume
CBIO Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
611 Gateway BoulevardSouth San Francisco, CA 94080US
Website:https://www.catalystbiosciences.com
Contact #:650 871 0761
Company Information
EmployeesN/A
BetaN/A
Sales or RevenueN/A
5Y Sales ChangeN/A
Fiscal Year EndsN/A
SectorHealthcare
IndustryBiotechnology
About Company
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD); and CB 4332 for patients with deficiencies in complement factor I (CFI), including dAMD. The company also develops ProTUNE C3b/C4b degrader and ImmunoTUNE C3a/C5a degrader platforms designed to target other disorders of the complement or inflammatory pathways. It has a strategic research collaboration with Mosaic Biosciences, Inc.; and license and collaboration agreement with Biogen International GmbH. Catalyst Biosciences, Inc. was founded in 2002 and is headquartered in South San Francisco, California.
Peers
Frequently Asked Questions
What is the current Catalyst Biosciences, Inc. (CBIO) stock price?
Catalyst Biosciences, Inc. (NASDAQ: CBIO) stock price is $0.51 in the last trading session. During the trading session, CBIO stock reached the peak price of $0.58 while $0.48 was the lowest point it dropped to. The percentage change in CBIO stock occurred in the recent session was -96.66% while the dollar amount for the price change in CBIO stock was -$14.78.
CBIO's industry and sector of operation?
The NASDAQ listed CBIO is part of Biotechnology industry that operates in the broader Healthcare sector. Catalyst Biosciences, Inc. , a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation.
Who are the executives of CBIO?
Dr. Grant Blouse M.Sc., Ph.D.
Chief Scientific Officer
Ms. Ana Kapor
Senior Director of Investor Relations & Corporation Communications
Dr. Tom Knudsen D.V.M., Ph.D.
Senior Vice President of Corporation Devel.
Ms. Seline E. Miller CPA
Senior Vice President of Fin., Interim Chief Financial & Principal Accounting Officer
How CBIO did perform over past 52-week?
CBIO's closing price is 0.13% higher than its 52-week low of $0.1887 where as its distance from 52-week high of $8.693999 is -0.90%.
How many employees does CBIO have?
Number of CBIO employees currently stands at N/A. CBIO operates from 611 Gateway Boulevard, South San Francisco, CA 94080, US.
Link for CBIO official website?
Official Website of CBIO is: https://www.catalystbiosciences.com
How do I contact CBIO?
CBIO could be contacted at phone #650 871 0761 and can also be accessed through its website. CBIO operates from 611 Gateway Boulevard, South San Francisco, CA 94080, US.
How many shares of CBIO are traded daily?
CBIO stock volume for the day was 460710.00 shares. The average number of CBIO shares traded daily for last 3 months was 69.46 Thousands.
What is the market cap of CBIO currently?
The market value of CBIO currently stands at $1.22 Billion with its latest stock price at $0.51 and N/A of its shares outstanding.